Review The SDS Document
DOWNLOADProduct Details
Formula
C26H20Cl2N4O4S
MW
555.44
Purity
>90%
Mode Of Action
antagonist
Drug Status
Discontinued in Phase 2
Target Name
leukocyte function-associated antigen-1 (LFA-1)
Research Area
DERMATOLOGY
Research Area Sub Group
Anti-psoriatic
Pharmacology
ENZYME-LINKED RECEPTORS
Pharmacology Area Sub Group
Integrins
Bio Chemical Notes
BMS-587101 acts as a leukocyte function-associated antigen-1 (LFA-1) receptor antagonist. Ref: Synfacts. 2010; 8, 0865-0865.